Hasil Pencarian - Evandro de Azambuja

Perbaiki Hasil
  1. 1
    How I treat metastatic triple-negative breast cancer

    How I treat metastatic triple-negative breast cancer oleh Evandro de Azambuja, Rafael Caparica

    Diterbitkan 2019-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Adjuvant CDK4/6 Inhibitors for Early Breast Cancer: How to Choose Wisely?

    Adjuvant CDK4/6 Inhibitors for Early Breast Cancer: How to Choose Wisely? oleh Elisa Agostinetto, Luca Arecco, Evandro de Azambuja

    Diterbitkan 2023-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Reply to: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer

    Reply to: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer oleh Elisa Agostinetto, Evandro de Azambuja, Matteo Lambertini

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Mixed response to chemotherapy in triple-negative breast cancer: A case report

    Mixed response to chemotherapy in triple-negative breast cancer: A case report oleh Elisa Agostinetto, Geraldine Gebhart, Jean-Christophe Noël, Evandro de Azambuja

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Are life-saving anticancer drugs reaching all patients? Patterns and discrepancies of trastuzumab use in the European Union and the USA.

    Are life-saving anticancer drugs reaching all patients? Patterns and discrepancies of trastuzumab use in the European Union and the USA. oleh Felipe Ades, Christelle Senterre, Dimitrios Zardavas, Evandro de Azambuja, Razvan Popescu, Martine Piccart

    Diterbitkan 2017-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Post-neoadjuvant treatment and the management of residual disease in breast cancer: state of the art and perspectives

    Post-neoadjuvant treatment and the management of residual disease in breast cancer: state of the art and perspectives oleh Rafael Caparica, Matteo Lambertini, Noam Pondé, Debora Fumagalli, Evandro de Azambuja, Martine Piccart

    Diterbitkan 2019-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Clinical outcomes of platinum-based chemotherapy in patients with advanced breast cancer: An 11-year single institutional experience

    Clinical outcomes of platinum-based chemotherapy in patients with advanced breast cancer: An 11-year single institutional experience oleh Maria Alice Franzoi, Rita Saúde-Conde, Sofia Cristóvão Ferreira, Daniel Eiger, Ahmad Awada, Evandro de Azambuja

    Diterbitkan 2021-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Antibody–drug conjugates: the evolving field of targeted chemotherapy for breast cancer treatment

    Antibody–drug conjugates: the evolving field of targeted chemotherapy for breast cancer treatment oleh Guilherme Nader-Marta, Chiara Molinelli, Véronique Debien, Diogo Martins-Branco, Philippe Aftimos, Evandro de Azambuja, Ahmad Awada

    Diterbitkan 2023-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysis

    Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysis oleh Matteo Lambertini, Mariana Brandão, Evandro de Azambuja, Christian Maurer, Patricia Klarmann Ziegelmann, Noam F Pondé, Arlindo Ferreira, Samuel Martel, Martine Piccart, Márcio Debiasi

    Diterbitkan 2020-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Tumour-infiltrating lymphocytes in non-invasive breast cancer: A systematic review and meta-analysis

    Tumour-infiltrating lymphocytes in non-invasive breast cancer: A systematic review and meta-analysis oleh Rafael Caparica, Marco Bruzzone, Elisa Agostinetto, Maria Alice Franzoi, Marcello Ceppi, Nina Radosevic-Robin, Frédérique Penault-Llorca, Karen Willard-Gallo, Sherene Loi, Roberto Salgado, Evandro de Azambuja

    Diterbitkan 2021-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer

    ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer oleh Fatima Cardoso, Dario Trapani, Carmen Criscitiello, Giuseppe Curigliano, Evandro de Azambuja, Sibylle Loibl, Suzette Delaloge, Elzbieta Senkus, Philip Poortman, Michael Gnant, Serena Di Cosimo, Javier Cortes, Shani Paluch-Shimon

    Diterbitkan 2020-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Effect of body mass index on response to neo-adjuvant therapy in HER2-positive breast cancer: an exploratory analysis of the NeoALTTO trial

    Effect of body mass index on response to neo-adjuvant therapy in HER2-positive breast cancer: an exploratory analysis of the NeoALTTO trial oleh Serena Di Cosimo, Luca Porcu, Dominique Agbor-tarh, Saverio Cinieri, Maria Alice Franzoi, Maria Carmen De Santis, Cristina Saura, Jens Huober, Debora Fumagalli, Miguel Izquierdo, Martine Piccart, Maria Grazia Daidone, Evandro de Azambuja

    Diterbitkan 2020-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer

    Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer oleh Tamar Zahavi, Mali Salmon-Divon, Roberto Salgado, Michael Elkin, Esther Hermano, Ariel M. Rubinstein, Prudence A. Francis, Angelo Di Leo, Giuseppe Viale, Evandro de Azambuja, Lieveke Ameye, Christos Sotiriou, Asher Salmon, Nataly Kravchenko-Balasha, Amir Sonnenblick

    Diterbitkan 2021-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    OncoAlert Round Table Discussions: The Global COVID-19 Experience

    OncoAlert Round Table Discussions: The Global COVID-19 Experience oleh Gilberto Morgan, Evandro de Azambuja, Kevin Punie, Felipe Ades, Kathrin Heinrich, Nicola Personeni, Ramy Rahme, Roberto Ferrara, Kevin Pels, Marina Garassino, Michael von Bergwelt-Baildon, Gilberto Lopes, Fabrice Barlesi, Toni K. Choueiri, Howard Burris, Solange Peters

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer

    PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer oleh Elisa Agostinetto, Lieveke Ameye, Samuel Martel, Philippe Aftimos, Noam Pondé, Christian Maurer, Sarra El-Abed, Yingbo Wang, Malou Vicente, Saranya Chumsri, Judith Bliss, Judith Kroep, Marco Colleoni, Fausto Petrelli, Lucia Del Mastro, Alvaro Moreno-Aspitia, Martine Piccart, Marianne Paesmans, Evandro de Azambuja, Matteo Lambertini

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months

    Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months oleh Begoña de las Heras, Kamal S. Saini, Frances Boyle, Felipe Ades, Evandro de Azambuja, Ivana Bozovic-Spasojevic, Marco Romano, Marta Capelan, Rajeev Prasad, Pugazhenthi Pattu, Christophe Massard, Chia Portera, Monika Lamba Saini, Brajendra Prasad Singh, Ramachandran Venkitaraman, Richard McNally, Manuela Leone, Enrique Grande, Sudeep Gupta

    Diterbitkan 2020-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer.

    Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer. oleh Michail Ignatiadis, Dimitrios Zardavas, Marc Lemort, Celine Wilke, Marie-Catherine Vanderbeeken, Veronique D'Hondt, Evandro De Azambuja, Andrea Gombos, Fabienne Lebrun, Lissandra Dal Lago, Fanny Bustin, Marion Maetens, Lieveke Ameye, Isabelle Veys, Stefan Michiels, Marianne Paesmans, Denis Larsimont, Christos Sotiriou, Jean-Marie Nogaret, Martine Piccart, Ahmad Awada

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis

    Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis oleh Márcio Debiasi, Márcio Debiasi, Carisi A. Polanczyk, Patrícia Ziegelmann, Carlos Barrios, Carlos Barrios, Hongyuan Cao, James J. Dignam, Paul Goss, Paul Goss, Brittany Bychkovsky, Brittany Bychkovsky, Dianne M. Finkelstein, Dianne M. Finkelstein, Rodrigo S. Guindalini, Rodrigo S. Guindalini, Paulo Filho, Caroline Albuquerque, Tomás Reinert, Evandro de Azambuja, Olufunmilayo Olopade

    Diterbitkan 2018-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study

    Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study oleh Luca Arecco, Maria Maddalena Latocca, Eva Blondeaux, Ferdinando Riccardi, Carmela Mocerino, Valentina Guarneri, Eleonora Mioranza, Giancarlo Bisagni, Elisa Gasparini, Fabio Puglisi, Alexandro Membrino, Antonella Ferro, Vincenzo Adamo, Filippo Giovanardi, Stefano Tamberi, Sara Donati, Elisabetta Landucci, Laura Biganzoli, Sara Piccinini, Simona Pastorino, Evandro de Azambuja, Francesca Poggio, Matteo Lambertini, Lucia Del Mastro

    Diterbitkan 2024-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy

    Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy oleh Serena Di Cosimo, Valentina Appierto, Sara Pizzamiglio, Marco Silvestri, José Baselga, Martine Piccart, Jens Huober, Miguel Izquierdo, Lorena de la Pena, Florentine S. Hilbers, Evandro de Azambuja, Michael Untch, Lajos Pusztai, Kathleen Pritchard, Paolo Nuciforo, Anne Vincent-Salomon, Fraser Symmans, Giovanni Apolone, Filippo G. de Braud, Marilena V. Iorio, Paolo Verderio, Maria Grazia Daidone

    Diterbitkan 2020-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: